Eastern Bank Makes New $62,000 Investment in HCA Healthcare, Inc. (NYSE:HCA)

Eastern Bank bought a new position in HCA Healthcare, Inc. (NYSE:HCA) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 205 shares of the company’s stock, valued at approximately $62,000.

A number of other large investors have also recently made changes to their positions in the stock. Terra Nova Asset Management LLC lifted its holdings in shares of HCA Healthcare by 0.3% during the 3rd quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock valued at $3,297,000 after buying an additional 26 shares during the period. Massmutual Trust Co. FSB ADV boosted its position in HCA Healthcare by 7.4% in the third quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock worth $171,000 after purchasing an additional 29 shares during the last quarter. Waldron Private Wealth LLC increased its position in shares of HCA Healthcare by 1.8% during the 3rd quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock valued at $683,000 after purchasing an additional 29 shares during the last quarter. Brookstone Capital Management grew its position in HCA Healthcare by 0.7% during the third quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock valued at $1,652,000 after buying an additional 30 shares during the period. Finally, UMB Bank n.a. boosted its stake in shares of HCA Healthcare by 2.4% during the 3rd quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock worth $529,000 after acquiring an additional 30 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

Insider Transactions at HCA Healthcare

In other news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now owns 6,843 shares of the company’s stock, valued at $2,415,579. The trade was a 29.76 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

HCA has been the topic of several analyst reports. Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and lowered their target price for the company from $400.00 to $320.00 in a research report on Monday, November 25th. KeyCorp decreased their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. Morgan Stanley decreased their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 17th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a research note on Tuesday, October 1st. Finally, Oppenheimer increased their target price on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research report on Monday, October 28th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $385.27.

HCA Healthcare Trading Down 0.8 %

HCA opened at $305.63 on Wednesday. The firm has a market cap of $77.42 billion, a P/E ratio of 13.72, a P/E/G ratio of 1.21 and a beta of 1.64. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The stock has a 50-day moving average of $319.34 and a 200 day moving average of $353.44. HCA Healthcare, Inc. has a 12 month low of $276.50 and a 12 month high of $417.14.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 27th. Shareholders of record on Friday, December 13th were given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.86%. The ex-dividend date of this dividend was Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.